Navigation Links
Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights
Date:10/23/2008

rials, difficulties or delays in manufacturing its clinical trials materials, the scope and validity of patent protection for its products, regulatory developments involving its product candidates and its ability to obtain additional funding to support its operations. Risk factors that may cause actual results to differ are more fully discussed in Anadys' SEC filings, including Anadys' Form 10-K for the year ended December 31, 2007 and Anadys' most recent Form 10-Q. All forward-looking statements are qualified in their entirety by this cautionary statement. Anadys is providing this information as of this date and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.

Condensed Consolidated Financial Statements

Anadys Pharmaceuticals, Inc.

Condensed Consolidated Statements of Operations

(In thousands except per share amounts)

(Unaudited)

Three Months Ended Nine Months Ended

September 30, September 30,

2008 2007 2008 2007

Revenues $-- $21,489 $-- $23,892

Operating expenses

Research and development(1) 7,581 7,602 19,091 21,275

General and administrative 2,084 2,444 6,104 6,844

Total operating expenses (2) 9,665 10,046 25,195 28,119

Interest income and other, net 316 864 1,311 2,855

Net (loss) income (2) $(9,349) $12,307 $(23,884) $(1,372)

Net (loss) income per share,

basic and diluted (2) $(0.32) $0.43 $(0.83) $(0.05)

Share used in calculating net

(loss) income per share,

basic and diluted
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
2. Anadys Pharmaceuticals to Report Third Quarter 2007 Financial Results
3. Anadys Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw Healthcare Conference
4. Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights
5. Anadys Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
6. Anadys Pharmaceuticals to Present at the JPMorgan Healthcare Conference
7. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
8. Anadys Pharmaceuticals to Report Fourth Quarter and Year-End 2007 Financial Results
9. Anadys Pharmaceuticals to Present at the Susquehanna SIGnificant Options in Healthcare Conference
10. Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients
11. Anadys Pharmaceuticals to Present at the Cowen and Company Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... REDWOOD CITY, California and HILDEN, ... -- QIAGEN N.V. (NASDAQ: QGEN ... commercial launch of its QIAGEN Clinical Insight ® ... clinical testing labs to interpret and report on ... first two supported applications for the bioinformatics platform ...
(Date:5/26/2015)... Miami, FL (PRWEB) May 26, 2015 ... training, Inc. have announced plans for the company’s first ... 9, 2015, followed by a full day, hands-on stem ... hosted by J. Victor Garcia Gimenez, M.D., President of ... to the medical community’s increasing interest in regenerative medicine ...
(Date:5/26/2015)... San Diego, CA (PRWEB) May 26, 2015 ... Biopharma, announced the beginning of a long-term relationship ... works on behalf of its members to provide ... “I am extremely pleased to count VGP as ... to more arthritic dog patients nationwide. Concentrating and ...
(Date:5/26/2015)... - Fluorinov Pharma (Fluorinov), a FACIT portfolio company, today ... to its Board of Directors.  His appointment strengthens Fluorinov,s ... Fluorinov accelerates its clinical development activities.  ... pleasure to welcome Luke to the Board of Directors.  ... financial strength and success of multiple organizations," said ...
Breaking Biology Technology:QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 2QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 3QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 4QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 5Stem Cell Training, Inc. Announces First European Symposium on Cellular and Regenerative Medicine 2Stem Cell Training, Inc. Announces First European Symposium on Cellular and Regenerative Medicine 3VetStem Biopharma & Veterinary Growth Partners Join Forces to Increase Member Veterinary Hospital Revenue Through Cutting Edge Medical Offering 2VetStem Biopharma & Veterinary Growth Partners Join Forces to Increase Member Veterinary Hospital Revenue Through Cutting Edge Medical Offering 3Luke M. Beshar Appointed to Fluorinov Pharma Board of Directors 2Luke M. Beshar Appointed to Fluorinov Pharma Board of Directors 3
... Mass. and TORONTO, April 4, 2011 ... GNBT) announced today the publication of a ... different immunotherapeutic peptide vaccines designed for immunotherapy ... is being developed by the Company,s wholly-owned ...
... April 4, 2011 ChromaDex Corporation (OTCBB: CDXC),an innovative ... and ingredients, today announced that Curtis A. Lockshin, ... Dr. Lockshin currently serves as ... K. Broad Biomedical Research Foundation, a Duke University ...
... Omeros Corporation (NASDAQ: OMER ), a biopharmaceutical ... on inflammation, bleeding and disorders of the central nervous ... and chief executive officer, is scheduled to present at ... New York City this week.  The presentation is scheduled ...
Cached Biology Technology:Generex Announces Publication of Comparative Peptide Vaccine Studies in Peer Review Journal Demonstrating Superiority of AE37 and Presentation at the American Association for Cancer Research 2Generex Announces Publication of Comparative Peptide Vaccine Studies in Peer Review Journal Demonstrating Superiority of AE37 and Presentation at the American Association for Cancer Research 3Generex Announces Publication of Comparative Peptide Vaccine Studies in Peer Review Journal Demonstrating Superiority of AE37 and Presentation at the American Association for Cancer Research 4ChromaDex Appoints Curtis Lockshin, Ph.D., to its Board of Directors 2
(Date:4/21/2015)... Canada , April 21, 2015 ... and evolving government policies are boosting access control systems ... According to a recently published report by ... Opportunities, 2020 ", the access control systems market in ... nearly USD1.2 billion by 2020.The access control systems market ...
(Date:4/14/2015)... OXFORD, Conn. , April 14, 2015 ... "Company"), a biometric authentication company focused on the growing ... has been nominated for the 2015 New York Design ... The Design100, New York City Design Awards are ... are based on over 2,500 ratings from the marketplace, ...
(Date:4/8/2015)... N.C. , April 8, 2015  Infinisource, ... solutions and services, and Morpho, a leading supplier ... partnership to produce the market,s most advanced biometrically-enabled ... Infinisource,s iSolved NXG time clock is setting a ... and labor data for the small and mid-size ...
Breaking Biology News(10 mins):Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3
... paper published today in the journal Science, scientists from ... University Hospital in Reykjavik and Uppsala University in Sweden ... (SNPs) in the sequence of the human genome that ... major subtype of glaucoma. The SNPs are located in ...
... -- Many people with long-standing high blood pressure develop ... and colleagues at Washington University School of Medicine in ... out what could explain that difference. , Their latest ... may underlie heart failure in some hypertensive patients. The ...
... if not deadly. While the desire for these substances can ... important role. The etiology of these desires is multifactorial and ... twin studies have shown that the use of these substances ... that ones sex can influence the genetic factors for alcohol ...
Cached Biology News:deCODE discovers cause of major subtype of glaucoma 2High blood pressure, low energy -- a recipe for heart failure 2Does the desire to consume alcohol and tobacco come from our genetic makeup? 2Does the desire to consume alcohol and tobacco come from our genetic makeup? 3
... The Neural Stem Cell Expansion Kit - ... vitro neural stem cell expansion as neurospheres ... a specially formulated N-2 Plus Media Supplement, which ... (Johe, K.K. et al . (1996) Genes ...
... thymus Description: Topoisomerase I relaxes both ... breakage and rejoining of phosphodiester bonds (1,2) . ... to be differentiated by a single nucleotide pair ... active in the absence of Mn 2+ ...
... I, Wild Type Liquid. In 100 ... 200 µM EDTA, 20% glycerol, pH 7.9. AVOID ... is a monomeric protein of 765 amino acids ... relaxation of both positive and negative supercoiled DNAs ...
DNA polymerase I, large fragment...
Biology Products: